Thank you Sam. That’s the kind of increase that I’ve been hoping to see and generic L grew well also meaning the whole market grew which is equally as important as I believe that those scripts will eventually become Vascepa scripts! Thank you once again for providing us this valuable information. I greatly appreciate all that you do.
As always Sam, thank you. Now we are cooking with gas and we have yet to get expanded label and proper insurance coverage. I would hope the market takes notice.
This is the same person that tweeted this yesterday:
GS healthcare conference - $IBB $XBI we hosted a panel with GS Investment Bankers, where panelists noted a high likelihood of another SMID biotech deal at a large premium this year, and of a mega-deal (>$50bn) in the biopharma industry in 2020